论文部分内容阅读
淋巴瘤是原发于淋巴结或淋巴结外组织或器官的恶性肿瘤。根据患者的临床和病理特点不同,可分为霍奇金淋巴瘤(HL)和非霍奇金淋巴瘤(NHL)两大类。恶性淋巴瘤治疗的关键是早期诊断、准确分期及疗效评估。近十年来大量临床研究
Lymphoma is a malignant tumor of the tissue or organ originating outside the lymph node or lymph node. According to the patient’s clinical and pathological features can be divided into Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL) two categories. The key to the treatment of malignant lymphoma is early diagnosis, accurate staging and efficacy evaluation. In the past decade a large number of clinical studies